Close

FDA Approves Kite/Gilead's (GILD) CAR-T Cell Therapy to Treat Adults with Certain Types of Large B-cell Lymphoma

October 18, 2017 5:36 PM EDT Send to a Friend
(Updated - October 18, 2017 5:48 PM EDT)The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login